administration) in EGFR-positive MDA-MB-231-derived tumors, but not in EGFR-negative tumors; (iii) durable tumor retention (at least 24 h) and (iv) no accumulation in healthy organs, i.e., lung and heart. The gene discussed is EGFR; the disease is neoplasm.